Since 2007, we have awarded about £5 million to promote research into BHD syndrome. During this time:

  • The number of researchers studying BHD syndrome has doubled.
  • The rate of publications about BHD has increased at least 5-fold.
  • Folliculin has been found to function in a number of signalling pathways and biological processes. Specifically its role in mTOR and HIF signaling link BHD syndrome to other genetic kidney disorders such as VHL, TSC, HLRCC and SDH.
  • The BHD Symposium was launched and more than 100 researchers, patients and clinicians attended the 2013 meeting in Paris.

See the Publications page for further information on these BHD advances. Alternatively, continue to learn about current Projects in BHD research.